abstract |
The present invention relates to anti-CD79B antibodies and immunoconjugates and methods of use. The present invention is directed to humanized, conjugated anti-CD79b antibodies useful for the treatment of hematopoietic tumors in mammals and methods of using the antibodies to treat hematopoietic tumors in mammals. |